Covance Not Cooling...
Health Care: Drugs
Astex Pharmaceuticals Inc (ASTX: NASDAQ)
$5.59 0.17 | 3.14%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 15.50M | 39.79M | 25.55M | 7.68M |
| Receivables | 5.95M | 8.15M | 40.00K | 904.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 146.51M | 136.57M | 116.62M | 99.25M |
| Property, Plant & Equipment, Gross | 14.07M | 17.61M | 13.99M | 13.14M |
| Accumulated Depreciation & Depletion | 8.32M | 10.60M | 10.06M | 8.93M |
| Property, Plant & Equipment, Net | 5.75M | 7.01M | 3.93M | 4.20M |
| Intangibles | 74.51M | 86.20M | 0.00 | 0.00 |
| Other Non-Current Assets | 1.60M | 2.37M | 7.81M | 6.33M |
| Total Non-Current Assets | 128.66M | 140.38M | 12.48M | 11.27M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 275.16M | 276.95M | 129.10M | 110.52M |
| Accounts Payable | 9.24M | 7.53M | 1.76M | 2.58M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 2.21M | 17.35M | 0.00 | 0.00 |
| Total Current Liabilities | 19.64M | 34.67M | 6.05M | 6.57M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 3.54M | 9.54M | 0.00 | 0.00 |
| Other Non-Current Liabilities | 15.04M | 12.73M | 1.44M | 1.96M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 18.58M | 22.28M | 1.44M | 1.96M |
| Total Liabilities | 38.22M | 56.95M | 7.49M | 8.53M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 236.94M | 220.00M | 121.61M | 101.99M |
| Common Par | 94.00K | 93.00K | 60.00K | 60.00K |
| Additional Paid In Capital | 565.15M | 561.36M | 459.48M | 457.71M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -326.52M | -334.77M | -340.31M | -356.58M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -1.78M | -6.68M | 2.38M | 797.00K |
| Total Capitalization | 236.94M | 220.00M | 121.61M | 101.99M |
| Total Equity | 236.94M | 220.00M | 121.61M | 101.99M |
| Total Liabilities & Stock Equity | 275.16M | 276.95M | 129.10M | 110.52M |
| Total Common Shares Outstanding | 93.57M | 93.05M | 60.36M | 60.20M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 93.26M | 75.07M | 60.29M | 59.32M |
| Diluted Weighted Shares Outstanding | 101.99M | 75.75M | 60.64M | 59.34M |
| Number of Employees | 136 | 149 | 97 | 80 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ASTX
- Portfolio NameUser Type
- UserMy SP portfolio
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserGopher Gold
- ContributorStocks Under-$10 Moving Hig...
Latest ASTX Headlines from TheStreet
- Astex Pharmaceuticals To Present At UBS Global Healthcare Conference 05.14.13 | 06:05 am
- Short Interest Moves 16% Higher For ASTX 05.10.13 | 03:05 pm
- Astex Pharmaceuticals Inc Stock Downgraded (ASTX) 05.01.13 | 05:05 am
- Astex Pharmaceuticals Reports 2013 First Quarter Financial Results 04.29.13 | 04:04 pm
- Astex Pharmaceuticals To Present At Needham Healthcare Conference 04.23.13 | 06:04 am
- Astex Pharmaceuticals To Announce 2013 First Quarter Financial Results On April 29th 04.22.13 | 06:04 am
- Astex Pharmaceuticals Provides SGI-110 Update 04.10.13 | 06:04 am
- Investing 'Systems' Take the Guesswork Out of Making Money 04.04.13 | 06:04 am
- Astex Pharmaceuticals Pipeline Data Presentations At AACR 04.03.13 | 06:04 am
- Astex Pharmaceuticals To Present At ROTH Conference 03.12.13 | 06:03 am
Press Releases for ASTX
- Astex Pharmaceuticals To Present At AACR Annual Meeting - Business Wire 03.29.12 | 06:03 am
- Astex Pharmaceuticals Announces March 27th Analyst And Investor Day Agenda - Business Wire 03.21.12 | 06:03 am
- Eisai Inc. Receives Complete Response Letter From The U.S. Food And Drug Administration For Dacogen® (decitabine) For Injection SNDA In Acute Myeloid Leukemia - Business Wire 03.06.12 | 09:03 pm
- Astex Pharmaceuticals Reports 2011 Fourth Quarter And Year-End Financial Results - Business Wire 03.05.12 | 04:03 pm
- Astex Pharmaceuticals To Announce 2011 Fourth Quarter And Year-End Financial Results On March 5, 2012 - Business Wire 02.28.12 | 06:02 am
- Astex Pharmaceuticals To Host Annual Analyst And Investor Day On March 27, 2012 - Business Wire 02.16.12 | 06:02 am
- FDA’s Oncologic Drugs Advisory Committee (ODAC) Votes To Not Support Benefit/Risk Profile Of DACOGEN® (decitabine) In Acute Myeloid Leukemia - Business Wire 02.09.12 | 01:02 pm
- Astex Pharmaceuticals Announces Presentations At Upcoming Conferences - Business Wire 02.06.12 | 06:02 am
- Astex Announces Early Transfer Of Epigenetics Project To GSK - Business Wire 01.16.12 | 06:01 am
- Astex Pharmaceuticals To Present At Biotech Showcase On January 9th - Business Wire 01.03.12 | 06:01 am
Partner Headlines for ASTX
- Biotech Stocks Get A Turbo Boost From Vertex - Seeking Alpha 04.20.13 | 09:04 am
- Astex Pharmaceuticals: Heading For New Highs On Strong Pipeline Momentum - Seeking Alpha 01.10.13 | 09:01 am
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Astex's Linear Rise Versus Peregrine's And Cell Therapeutics' Sudden Pop - Seeking Alpha 09.10.12 | 09:09 am
- One Stock To Buy, Two Avoids, And A Swing Trade From Last Week's Big Biotech News Movers - Seeking Alpha 07.21.12 | 06:07 am
- 3 Rising Biotech Stars All Under $2/Share - Seeking Alpha 06.18.12 | 09:06 am
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
